Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
Go back to Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer| CARA THERAPEUTICS (NASDAQ: CARA) | Delayed: 5.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.32 | 52 Week High | $17.69 | |||
| Open | $5.32 | 52 Week Low | $4.26 | |||
| Day High | $5.32 | P/E | N/A | |||
| Day Low | $5.32 | EPS | $-0.42 | |||
| Volume | 410 | |||||
| (NASDAQ: IOVA) | Delayed: 4.34 -0.02 (0.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $ | |||
| Open | $4.45 | 52 Week Low | $ | |||
| Day High | $4.55 | P/E | N/A | |||
| Day Low | $4.29 | EPS | $ | |||
| Volume | 15,585,980 | |||||
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 40.48 +1.78 (4.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.70 | 52 Week High | $4.38 | |||
| Open | $42.48 | 52 Week Low | $1.88 | |||
| Day High | $43.49 | P/E | N/A | |||
| Day Low | $38.18 | EPS | $-1.12 | |||
| Volume | 748,878 | |||||
